These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 35894480

  • 1. Plasma Lnc-UCA1/miR-138 axis as a potential biomarker for gestational diabetes mellitus and neonatal prognosis.
    Leng B, Chen F, Li M, Yin H, Sun G, Zhao Y.
    Ginekol Pol; 2023; 94(10):845-851. PubMed ID: 35894480
    [Abstract] [Full Text] [Related]

  • 2. Serum miR-195-5p is upregulated in gestational diabetes mellitus.
    Wang J, Pan Y, Dai F, Wang F, Qiu H, Huang X.
    J Clin Lab Anal; 2020 Aug; 34(8):e23325. PubMed ID: 32301163
    [Abstract] [Full Text] [Related]

  • 3. The Expression and Clinical Value of miR-221 and miR-320 in the Plasma of Women with Gestational Diabetes Mellitus.
    Niu S, Yu K, Wang W, Tan X, Xin H, Wu M.
    Clin Lab; 2022 Jul 01; 68(7):. PubMed ID: 35975537
    [Abstract] [Full Text] [Related]

  • 4. The Predictive Value of miR-16, -29a and -134 for Early Identification of Gestational Diabetes: A Nested Analysis of the DALI Cohort.
    Sørensen AE, van Poppel MNM, Desoye G, Damm P, Simmons D, Jensen DM, Dalgaard LT, The DALI Core Investigator Group.
    Cells; 2021 Jan 15; 10(1):. PubMed ID: 33467738
    [Abstract] [Full Text] [Related]

  • 5. miR-96-5p: A potential diagnostic marker for gestational diabetes mellitus.
    Yu X, Liu Z, Fang J, Qi H.
    Medicine (Baltimore); 2021 May 28; 100(21):e25808. PubMed ID: 34032694
    [Abstract] [Full Text] [Related]

  • 6. Serum miR-29a/b expression in gestational diabetes mellitus and its influence on prognosis evaluation.
    Deng L, Huang Y, Li L, Chen H, Su J.
    J Int Med Res; 2020 Sep 28; 48(9):300060520954763. PubMed ID: 32993411
    [Abstract] [Full Text] [Related]

  • 7. LncRNA UCA1, miR-26a, and miR-195 in coronary heart disease patients: Correlation with stenosis degree, cholesterol levels, inflammatory cytokines, and cell adhesion molecules.
    Li J, Chen Z, Wang X, Song H.
    J Clin Lab Anal; 2022 Jan 28; 36(1):e24070. PubMed ID: 34850451
    [Abstract] [Full Text] [Related]

  • 8. miR-132 serves as a diagnostic biomarker in gestational diabetes mellitus and its regulatory effect on trophoblast cell viability.
    Zhou X, Xiang C, Zheng X.
    Diagn Pathol; 2019 Oct 25; 14(1):119. PubMed ID: 31653266
    [Abstract] [Full Text] [Related]

  • 9. Elevated circulating lnc-ANRIL/miR-125a axis level predicts higher risk, more severe disease condition, and worse prognosis of sepsis.
    Gui F, Peng H, Liu Y.
    J Clin Lab Anal; 2019 Jul 25; 33(6):e22917. PubMed ID: 31115097
    [Abstract] [Full Text] [Related]

  • 10. Lnc-MEG3 acts as a potential biomarker for predicting increased disease risk, systemic inflammation, disease severity, and poor prognosis of sepsis via interacting with miR-21.
    Na L, Ding H, Xing E, Gao J, Liu B, Wang H, Yu J, Yu C.
    J Clin Lab Anal; 2020 Apr 25; 34(4):e23123. PubMed ID: 31907972
    [Abstract] [Full Text] [Related]

  • 11. Decreased Expression of miR-185 in Serum and Placenta of Patients with Gestational Diabetes Mellitus.
    Qi S, Wang X.
    Clin Lab; 2019 Dec 01; 65(12):. PubMed ID: 31850721
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-33a-5p sponges to inhibit pancreatic β-cell function in gestational diabetes mellitus LncRNA DANCR.
    Feng Y, Qu X, Chen Y, Feng Q, Zhang Y, Hu J, Li X.
    Reprod Biol Endocrinol; 2020 Jun 06; 18(1):61. PubMed ID: 32505219
    [Abstract] [Full Text] [Related]

  • 13. Expression and diagnostic value of lncRNA HCG18 in gestational diabetes mellitus.
    Chen L, Jiang J, Tian Y.
    Ginekol Pol; 2023 Oct 16. PubMed ID: 37842995
    [Abstract] [Full Text] [Related]

  • 14. Exosomal RNA Expression Profiles and Their Prediction Performance in Patients With Gestational Diabetes Mellitus and Macrosomia.
    Yuan Y, Li Y, Hu L, Wen J.
    Front Endocrinol (Lausanne); 2022 Oct 16; 13():864971. PubMed ID: 35547007
    [Abstract] [Full Text] [Related]

  • 15. Cardiovascular Disease-Associated MicroRNAs as Novel Biomarkers of First-Trimester Screening for Gestational Diabetes Mellitus in the Absence of Other Pregnancy-Related Complications.
    Hromadnikova I, Kotlabova K, Krofta L.
    Int J Mol Sci; 2022 Sep 13; 23(18):. PubMed ID: 36142536
    [Abstract] [Full Text] [Related]

  • 16. Up-regulation of TGFBI and TGFB2 in the plasma of gestational diabetes mellitus patients and its clinical significance.
    Zhou H, Chen P, Dai F, Wang J.
    Ir J Med Sci; 2022 Oct 13; 191(5):2029-2033. PubMed ID: 34792732
    [Abstract] [Full Text] [Related]

  • 17. Identification and Validation of miR-222-3p and miR-409-3p as Plasma Biomarkers in Gestational Diabetes Mellitus Sharing Validated Target Genes Involved in Metabolic Homeostasis.
    Filardi T, Catanzaro G, Grieco GE, Splendiani E, Trocchianesi S, Santangelo C, Brunelli R, Guarino E, Sebastiani G, Dotta F, Morano S, Ferretti E.
    Int J Mol Sci; 2022 Apr 12; 23(8):. PubMed ID: 35457094
    [Abstract] [Full Text] [Related]

  • 18. Circulating lncRNAs NONHSAT054669.2 and ENST00000525337 can be used as early biomarkers of gestational diabetes mellitus.
    Jiang W, Sun X, Liu F, Cheng G, Li S, Xu M, Wu Y, Wang L.
    Exp Biol Med (Maywood); 2023 Mar 12; 248(6):508-518. PubMed ID: 37070250
    [Abstract] [Full Text] [Related]

  • 19. NR2C2-uORF targeting UCA1-miR-627-5p-NR2C2 feedback loop to regulate the malignant behaviors of glioma cells.
    Fan Z, Zheng J, Xue Y, Liu X, Wang D, Yang C, Ma J, Liu L, Ruan X, Wang Z, Liu Y.
    Cell Death Dis; 2018 Dec 05; 9(12):1165. PubMed ID: 30518750
    [Abstract] [Full Text] [Related]

  • 20. Differential expression of candidate circulating microRNAs in maternal blood leukocytes of the patients with preeclampsia and gestational diabetes mellitus.
    Hocaoglu M, Demirer S, Senturk H, Turgut A, Komurcu-Bayrak E.
    Pregnancy Hypertens; 2019 Jul 05; 17():5-11. PubMed ID: 31487656
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.